Tracy Hampton. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Adverse Drug Reaction Reporting SystemsClinical Trials as TopicCost-Benefit AnalysisCyclooxygenase Inhibitors/adverse effectsCyclooxygenase Inhibitors/economicsHumansLactones/adverse effectsLactones/economicsSulfones/adverse effectsSulfones/economicsUnited StatesUnited States Food and Drug Administration
Substances: See more » Cyclooxygenase InhibitorsLactonesSulfonesrofecoxib
Year: 2005 PMID: 15671414 DOI: 10.1001/jama.293.4.413
Source DB: PubMed Journal: JAMA ISSN: 0098-7484 Impact factor: 56.272